Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 564

1.

JAK and MPL mutations in myeloid malignancies.

Tefferi A.

Leuk Lymphoma. 2008 Mar;49(3):388-97. doi: 10.1080/10428190801895360. Review.

PMID:
18297515
2.

MPL W515L mutation in Chinese patients with myeloproliferative diseases.

Xu W, Li JY, Xia J, Zhang SJ, Fan L, Qiao C.

Leuk Lymphoma. 2008 May;49(5):955-8. doi: 10.1080/10428190802035966.

PMID:
18464114
3.

JAK-2 mutations and their relevance to myeloproliferative disease.

Levine RL, Gilliland DG.

Curr Opin Hematol. 2007 Jan;14(1):43-7. Review.

PMID:
17133099
4.

[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].

Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A.

Orv Hetil. 2006 Nov 12;147(45):2175-9. Hungarian.

PMID:
17402211
5.

JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science.

Kilpivaara O, Levine RL.

Leukemia. 2008 Oct;22(10):1813-7. doi: 10.1038/leu.2008.229. Epub 2008 Aug 28. Review.

PMID:
18754026
6.

Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.

Pikman Y, Levine RL.

Curr Opin Oncol. 2007 Nov;19(6):628-34. Review.

PMID:
17906464
7.

JAK2 mutations and clinical practice in myeloproliferative neoplasms.

Tefferi A.

Cancer J. 2007 Nov-Dec;13(6):366-71. Review.

PMID:
18032973
8.

TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations.

Pardanani A, Hood J, Lasho T, Levine RL, Martin MB, Noronha G, Finke C, Mak CC, Mesa R, Zhu H, Soll R, Gilliland DG, Tefferi A.

Leukemia. 2007 Aug;21(8):1658-68. Epub 2007 May 31.

PMID:
17541402
9.
10.

JAK2 and MPL gene mutations in V617F-negative myeloproliferative neoplasms.

Siemiatkowska A, Bieniaszewska M, Hellmann A, Limon J.

Leuk Res. 2010 Mar;34(3):387-9. doi: 10.1016/j.leukres.2009.06.017. Epub 2009 Jul 29.

PMID:
19643476
11.

JAK2 and MPL mutations in myeloproliferative neoplasms.

Koppikar P, Levine RL.

Acta Haematol. 2008;119(4):218-25. doi: 10.1159/000140634. Epub 2008 Jun 20. Review.

PMID:
18566540
12.
13.

MPL mutation profile in JAK2 mutation-negative patients with myeloproliferative disorders.

Ma W, Zhang X, Wang X, Zhang Z, Yeh CH, Uyeji J, Albitar M.

Diagn Mol Pathol. 2011 Mar;20(1):34-9. doi: 10.1097/PDM.0b013e3181ecd261.

PMID:
21326037
14.

Differences in the JAK2 and MPL mutation status in the cell lineages of the bcr/abl-negative chronic myeloproliferative neoplasm subtypes.

Toyama K, Karasawa M, Yokohama A, Mitsui T, Uchiumi H, Saitoh T, Handa H, Murakami H, Nojima Y, Tsukamoto N.

Intern Med. 2011;50(21):2557-61. Epub 2011 Nov 1.

16.

MPL W515L/K mutations in 343 Chinese adults with JAK2V617F mutation-negative chronic myeloproliferative disorders detected by a newly developed RQ-PCR based on TaqMan MGB probes.

Ruan GR, Jiang B, Li LD, Niu JH, Li JL, Xie M, Qin YZ, Liu YR, Huang XJ, Chen SS.

Hematol Oncol. 2010 Mar;28(1):33-9. doi: 10.1002/hon.899.

PMID:
19274616
17.

Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal.

Vannucchi AM, Antonioli E, Guglielmelli P, Pardanani A, Tefferi A.

Leukemia. 2008 Jul;22(7):1299-307. doi: 10.1038/leu.2008.113. Epub 2008 May 22. Review.

PMID:
18496562
18.

Detection of MPL exon10 mutations in 103 Chinese patients with JAK2V617F-negative myeloproliferative neoplasms.

Chen X, Qi X, Tan Y, Xu Z, Xu A, Zhang L, Wang H.

Blood Cells Mol Dis. 2011 Jun 15;47(1):67-71. doi: 10.1016/j.bcmd.2011.04.004. Epub 2011 May 8.

PMID:
21555228
19.

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients.

Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M, Steensma DP, Elliott MA, Wolanskyj AP, Hogan WJ, McClure RF, Litzow MR, Gilliland DG, Tefferi A.

Blood. 2006 Nov 15;108(10):3472-6. Epub 2006 Jul 25.

20.

The analysis of JAK2 and MPL mutations and JAK2 single nucleotide polymorphisms in MPN patients by MassARRAY assay.

Zhang SJ, Qiu HX, Li JY, Shi JY, Xu W.

Int J Lab Hematol. 2010 Aug 1;32(4):381-6. doi: 10.1111/j.1751-553X.2009.01208.x. Epub 2010 Mar 23.

PMID:
20331763

Supplemental Content

Support Center